Skip to content
triangle-white-good

FEATURED ARTICLE

From Biocentury.com: ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

FEATURED ARTICLE

From Biocentury.com: ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

VIEW BY
second-menu-section

NEWS PAGE

20 May, 2019

From genomeweb.com: Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract

READ MORE

20 May, 2019

Press Release: Inteliquet Signs Cooperative R&D Agreement (CRADA) with the National Cancer Institute

Inteliquet announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI). The principal goal of this research agreement is to develop a clinic-ready, web-based tool, using NCI’s Oncogenomics browser with Inteliquet’s proprietary Precision Medicine Platform to aid clinicians in therapeutic decision-making.
READ MORE

16 May, 2019

From Forbes.com: Genomic Data Carve A New Path For Consumers, Clinical Trials

CEO Carla Balch discusses how Inteliquet is reimagining the clinical trial process using health and genetic data.
READ MORE

25 April, 2019

From European Pharmaceutical Manufacturer: How Going Digital Can Solve Recruitment Problems For Clinical Trials

READ MORE

15 April, 2019

Press Release: TransMed Systems Rebrands as Inteliquet

TransMed Systems, Inc., a leading provider of technology, insights and services for clinical research and translational medicine announced today it has rebranded the company as Inteliquet.
READ MORE

INTELIQUET MEDIA CONTACT

Chris Gale, Vice President

Greentarget Global Group

Phone: 646-695-2883

Email: cgale@greentarget.com

LEARN MORE

Would you like a demo? More information? Let us know how we can help. We’ll contact you shortly.